Urinary Incontinence in Women: Never an Acceptable Consequence of Aging
|
|
- Solomon Lester
- 6 years ago
- Views:
Transcription
1 Urinary Incontinence in Women: Never an Acceptable Consequence of Aging Catherine A. Matthews, MD Associate Professor Chief, Urogynecology and Pelvic Reconstructive Surgery University of North Carolina, Chapel Hill Disclosures! No conflicts of interest to report
2 Objectives! Review prevalence data regarding UI in women! Understand different types of UI! Review a non-specialist evaluation algorithm for UI! Describe evidence-based treatment options for SUI and OAB Prevalence of stress urinary incontinence by age and severity. Minassian et al. Obstet Gynecol 2008
3 Prevalence of urge urinary incontinence by age and severity Prevalence of any urinary incontinence by age and severity
4 7 Changing the Face of Urinary Incontinence: It Also Affects Younger Women Stereotype Reality For illustrative purposes only. Not indicative of population distribution. Case # 1! 55 yo PMP WF who complains of a 10-year history of leaking with coughing and while playing tennis. Has primarily coped by keeping my bladder empty. Cannot confidently leave the house without a pad. She also reports significant depression.
5 Evaluation and management! Urinalysis! Simple pelvic examination Treatment options! Incontinence pessary (ring with a knob) or tampon! Physical Therapy! Medication! Referral for surgery (minimally invasive suburethral sling)
6 Pelvic Muscle Rehabilitation TVT versus TOT Barber et al. Obstet Gynecol 2008.! Non-inferiority study that assessed the presence or absence of abnormal bladder function: Any UI; positive cough test; retention.! N= 171 with urodynamic stress incontinence and no detrusor overactivity
7 TVT versus TOT. N=170 Case # 2! 62 yo AAF with complaints of getting up at least 6 times during night to void with accompanying urgency. No enuresis. She is exhausted. Voids q 4 hours during day. Mild leakage with coughnot bothersome.
8 Urinary incontinence should not be considered just a disease of the bladder, but rather as a sign of an underlying problem (s). Questions?! ICS definition of OAB: Urgency with or without urge UI, usually accompanied by frequency and nocturia.! Does this patient have OAB?! OAB versus nocturnal polyuria! Evaluation and Treatment algorithm?
9 Nocturia versus nocturnal polyuria! Determined by simple 24 hour urine collection! Common causes: Sleep apnea (ANP), CHF, diabetes mellitus! Sleep Apnea Most under-recognized cause of nocturnal polyuria Treatment with CPAP significantly reduces nocturic frequency (Fitzgerald et al, Am J Obstet Gynecol, 2006). Nocturnal polyuria and nocturia relief in patients treated with Solifenacin Nocturia Episodes Placebo 5 mg Solifenacin 10 mg Solifenacin Mean baseline Mean actual change (p=.025) -0.6 (p<.001) Mean % change -25% -35.5% (p=.021) -36.4% (p<.001) Brubaker et al. Int Urogynecol J, 2007
10 Sub-analysis! In patients with NP- no significant effect! Conclusion: Solifenacin will not provide effective treatment relief in patients whose OAB is complicated by NP Case # 3! 48 yo perimenopausal WF with urgency, frequency, and occasional urge UI. Anxious and nervous that she will embarrass herself in public. Has noticed a significant decline in sexual satisfaction and activity with onset of her bladder problems.! Medications: HCTZ and Propranolol for HTN
11 A Practical Approach!Medical History!Screening questions!urinalysis!physical Examination
12 Screening Questions must include an intake/output diary Caffeine Causes OAB by releasing intracellular Ca+ + Parasympathetic Nerve Ca+ + Sympathetic Nerve
13 Lower Urinary Tract Function! Bladder and urethral functions Storage Micturition! These functions are controlled by the central nervous system (CNS) through reflexes that coordinate the activity of Bladder (smooth muscle) Urethra (smooth and striated muscles) Pelvic floor muscles NeuroUrology Storage Reflex Micturition Reflex Inhibition Spinal Reflex - ß 3 Bladder Hypogastric N. Pelvic N. + M 2,3 + " 1 +N Rhabdosphincter Pudendal N. SYM Periaquaductal ON Gray Spinal Relay Neuron Pontine Micturition Center PAR
14 Lower Urinary Tract Innervation Pelvic Nerve (Parasympathetic) ACh Hypogastric Nerve (Sympathetic) NE +M 3 -# 3 +" 1 +N Pudendal Nerve (Somatic) ACh
15 Detrol LA (tolterodine tartrate extended release capsules) Receptor Selectivity Inhibition Constant Ratio (K i ) for Muscarinic Receptor Subtypes* Nonselective (M 3 /M 2 ) M 3 selective Primarily M 3 selective Trospium Tolterodine Solifenacin Oxybutynin Darifenacin *Animal models. Please see full prescribing information. Heading CE. Curr Opin CPNS Investig Drugs. 2000;3: Napier C et al. Proc ICS. 2002:445. Abstract.
16 M-3 Selective Antagonists! Solifenacin! Darifenacin STAR Trial: N=1200!12-week, European, prospective, randomized, double-blind, doubledummy, 2-arm, parallel-group trial!dose titration regimen of solifenacin (5 mg or 10 mg qd) or a single dose of Tolterodine LA 4 mg qd!inclusion Criteria Average of!8 micturitions per 24 hours Average of!1 incontinence episode per 24 hours, or an average of!1 urgency episode per 24 hours!primary OBJECTIVE: Non-inferiority study!primary END-POINT: Micturition frequency!secondary end points: Incontinence episodes, urge incontinence episodes, urgency, volume voided, and tolerability Chapple CR et al. Eur Urol., 2005
17 STAR Trial Reported End Points End Point PRIMARY (non-inferiority) [PPS]* Solifenacin (pooled 5 mg/10 mg) (n=525) Tolterodine (4 mg qd) (n=524) P value *Per protocol set. Full analysis set. Micturition frequency/24 h =0.004 SECONDARY (FAS) (n=578) (n=599) Urgency episodes/24 h =0.035 Incontinence episodes/24 h =0.006 Nocturia episodes =0.730 Urge incontinence episodes/24 h <0.01 Mean volume voided (ml/void) =0.01 Patients dry (%) =0.006 Pads/24 h = Perception of bladder condition = Please see full prescribing information. Chapple CR et al. Eur Urol, Darifenacin! Bladder selectivity (marginal) in animal studies: Not more than Tolterodine or Oxybutynin in guinea-pig! Haab et al, Eur Urol 2004: Multicenter, placebocontrolled RCT (n=561); Reduction in incontinent episodes: 67.7% Darifenacin 7.5 mg (p=0.010) 72.8% Darifenacin 15 mg (p= 0.017) 55.9% Placebo No reductions in nocturia
18 Darifenacin and warning time? Cardozo et al. J Urol, 2005 Difference in Medians at Week 2 = 4.3 minutes (p=.003) N=32 N=35 Non-selective muscarinic antagonists!trospium
19 Trospium! Quaternary amine! Used in Europe for 20 years: Many studies! Efficacy not different from standard agents! Poor bioavailability! RCT in US (phase III, Zinner et al J Urol 2004): N= mg bid Urge UI -59% drug versus -44% placebo Nocturnal frequency decreased by week 4 Side effects: Dry mouth 21.8% CNS Considerations in the Treatment of Overactive Bladder : Passive Diffusion Across the BBB!$ Lipophilicity $ Diffusion Vasculature BBB CNS!$ Charge/polarity, hydrogen bonding % Diffusion % Molecular bulkiness $ Diffusion Pardridge WM. J Neurochem. 1998;70: Habgood MD et al. Cell Mol Neurobiol. 2000;
20 Conclusions! Urinary Incontinence is very common and has a profound negative impact on QOL! Simple questions can discriminate between basic types of UI! Look for underlying medical conditions and medications that exacerbate the problem! Initiate treatment or make a referral
Objectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS
URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS Lisa S Pair, MSN, CRNP Division of Urogynecology and Pelvic Reconstructive Surgery Department of Obstetrics and Gynecology University of Alabama
More informationUrinary Incontinence for the Primary Care Provider
Urinary Incontinence for the Primary Care Provider Diana J Scott FNP-BC https://youtu.be/gmzaue1ojn4 1 Assessment of Urinary Incontinence Urge Stress Mixed Other overflow, postural, continuous, insensible,
More informationSELECTED POSTER PRESENTATIONS
SELECTED POSTER PRESENTATIONS The following summaries are based on posters presented at the American Urogynecological Society 2004 Scientific Meeting, held July 29-31, 2004, in San Diego, California. CENTRAL
More information3/20/10. Prevalence of OAB Men: 16.0% Women: 16.9% Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Dry. Population (millions) Wet
1 Prevalence of OAB Men: 16.0% Women: 16.9% Stewart WF, et al. World J Urol. 2003;20:327-336. Prevalence of OAB with incontinence (OAB wet) Men: 2.6% Women: 9.3% Stewart WF, et al. World J Urol. 2003;20:327-336.
More informationThe Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence
european urology supplements 5 (2006) 849 853 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence Stefano
More informationManagement of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals
Management of OAB Lynsey McHugh Consultant Urological Surgeon Lancashire Teaching Hospitals Summary Physiology Epidemiology Definitions NICE guidelines Evaluation Conservative management Medical management
More informationManagement of Female Stress Incontinence
Management of Female Stress Incontinence Dr. Arvind Goyal Associate Professor (Urology& Renal Transplant) Dayanand Medical College & Hospital, Ludhiana, Punjab, India Stress Incontinence Involuntary loss
More informationUrinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital
Urinary Incontinence Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital Affects women of all ages Impacts physical, psychological & social wellbeing Impact on families & carers Costs the
More informationEvaluation & Management of Overactive Bladder
Evaluation & Management of Overactive Bladder Disclosures/Conflict of Interest/Bias I have no financial relationship with any of the companies that produce the products I m about to discuss I have no conflicts
More informationUrinary incontinence (UI) affects as many
EXPLORING NEW HORIZONS IN STRESS INCONTINENCE: THE NEUROUROLOGY CONNECTION W. Glenn Hurt, MD* ABSTRACT As many as one-third of women are affected by urinary incontinence, the most common of which being
More informationOveractive Bladder in Clinical Practice
Overactive Bladder in Clinical Practice Alan J. Wein Christopher Chapple Overactive Bladder in Clinical Practice Authors Alan J. Wein Division of Urology University of Pennsylvania Health System Philadelphia
More informationAnticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
Página 1 de 6 PubMed darifenacin vs solifenacin Display Settings:, Sorted by Recently Added Results: 5 1. Int Urogynecol J. 2013 Oct 25. [Epub ahead of print] Anticholinergic medication use for female
More informationOveractive Bladder Syndrome
Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive
More informationLower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist
Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,
More informationDiane K. Newman DNP, ANP-BC, PCB-PMD, FAAN
Diane K. Newman DNP, ANP-BC, PCB-PMD, FAAN Diane K. Newman, DNP is a Biofeedback Certified Continence Specialist. With over 35-years experience, she is an expert in the assessment and management of pelvic-floor
More informationFemale Urinary Incontinence
Primary Care Internal Medicine Female Urinary Incontinence May Wakamatsu, MD MGH Vincent Obstetrics & Gynecology Dept Division of Female Pelvic Medicine & Reconstructive Surgery 2015 Female Urinary Incontinence
More informationDiagnosis and Mangement of Nocturia in Adults
Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology
More informationTREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH
TREATMENT OF OVERACTIVE BLADDER IN ADULTS FUGA 2016 KGH CONTENTS Overactive bladder (OAB) Treatment of OAB Beta-3 adrenoceptor agonist (Betmiga ) - Panacea? LASER treatment - a flash in the pan or the
More informationUrinary Incontinence. Lora Keeling and Byron Neale
Urinary Incontinence Lora Keeling and Byron Neale Not life threatening. Introduction But can have a huge impact on quality of life. Two main types of urinary incontinence (UI). Stress UI leakage on effort,
More informationThe Neurogenic Bladder
The Neurogenic Bladder Outline Brandon Haynes, MD Resident Physician Department of Urology Jelena Svircev, MD Assistant Professor Department of Rehabilitation Medicine Anatomy and Bladder Physiology Bladder
More informationInnovations in Childhood Incontinence: Neurogenic and Functional Bladder Disorders
TNe 10 Innovations in Childhood Incontinence: Neurogenic and Functional Bladder Disorders Stuart B. Bauer, MD President, ICCS Department of Urology Children s Hospital Boston Professor of Urology Harvard
More informationOveractive bladder can result from one or more of the following causes:
Overactive bladder can affect people of any age; however, it is more common in older people. Effective treatments are available and seeing your doctor for symptoms of overactive bladder often results in
More informationUrogynecology Office. Can You Hold? An Update on the Treatment of OAB. Can You Hold? Urogynecology Office
Urogynecology Office Urogynecology Office Can You Hold? An Update on the Treatment of OAB Can You Hold? Karen Noblett, MD Professor and Chair Department of OB/GYN University of California, Riverside Disclosures
More informationTHE OVER-ACTIVE BLADDER (OAB)
THE OVER-ACTIVE BLADDER (OAB) Passage of urine is caused by the bladder muscle contracting coordinated with the relaxation of the sphincter muscles, which is controlled by higher centers in the central
More informationParkinson s Disease and Multiple System Atrophy
Parkinson s Disease and Multiple System Atrophy Jalesh N. Panicker MD, FRCP Department of Uro-Neurology National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology Queen Square, London
More informationOffice based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2
Office based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2 1 The Male Health Centre, Oakville, Ontario, Canada 2 Humber River Regional Hospital, University of Toronto, Toronto,
More informationReport on New Patented Drugs - Vesicare
Report on New Patented Drugs - Vesicare Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of applying the Board's Excessive
More informationNormal micturition involves complex
NEW TARGET FOR INTERVENTION: THE NEUROUROLOGY CONNECTION * Donald R. Ostergard, MD, FACOG ABSTRACT Urine storage and release are under the control of the parasympathetic, sympathetic, and somatic nervous
More informationTools for Evaluation. Urodynamics Case Studies. Case 1. Evaluation. Case 1. Bladder Diary SUI 19/01/2018
Urodynamics Case Studies Christopher K. Payne, MD Vista Urology & Pelvic Pain Partners Emeritus Professor of Urology, Stanford University Tools for Evaluation Ears, Eyes, and Brain Bladder diary Stress
More informationAdvanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa
Advanced Care for Female Overactive Bladder & Urinary Incontinence Department of Urology Kaiser Permanente Santa Rosa Goals Participants will: Review normal urinary tract anatomy and function Understand
More informationOveractive Bladder (OAB) and Quality of Life
Overactive Bladder (OAB) and Quality of Life Dr. Byron Wong MBBS (Sydney), FRCSEd, FRCSEd (Urol), FCSHK, FHKAM (Surgery) Specialist in Urology Central Urology Clinic Hong Kong Continence Society Annual
More informationSolifenacin significantly improves all symptoms of overactive bladder syndrome
REVIEW doi: 10.1111/j.1742-1241.2006.01067.x Solifenacin significantly improves all symptoms of overactive bladder syndrome C. R. CHAPPLE, 1 L. CARDOZO, 2 W. D. STEERS, 3 F. E. GOVIER 4 1 Department of
More informationThis Special Report supplement
...INTRODUCTION... Overactive Bladder: Defining the Disease Alan J. Wein, MD This Special Report supplement to The American Journal of Managed Care features proceedings from the workshop, Overactive Bladder:
More informationStudy No. 178-CL-008 Report Final Version, 14 Dec 2006 Reissued Version, 18 Jul 2011 Astellas Pharma Europe B.V. Page 13 of 122
Page 13 of 122 3 SYNOPSIS Title of study: (International) Study No: A randomized, double-blind, parallel group, proof-of-concept study of in comparison with placebo and tolterodine in patients with symptomatic
More informationComparison of Side Effects of Tolterodine and Solifenacinsucinate in Patients with Urinary Incontinence
ORIGINAL ARTICLE Comparison of Side Effects of Tolterodine and Solifenacinsucinate in Patients with Urinary Incontinence MARYAM RANA, IRAM MOBUSHER ABSTRACT Background: Overactive bladder syndrome is a
More informationOveractive Bladder: Identifying Patients at Risk, Implementing New Strategies
Overactive Bladder: Identifying Patients at Risk, Implementing New Learning Objectives Identify patients with OAB risk factors in order to proactively initiate a discussion about bladder symptoms and establish
More informationURINARY INCONTINENCE. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara Definition The involuntary loss of urine May denote a symptom, a sign or a condition Symptom the
More informationThe International Continence Society
REPORTS Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults Richard G. Roberts, MD, JD; Alan D. Garely, MD; and Tamara Bavendam, MD Abstract This article evaluates
More informationUpdates in the nonpharmacological. treatment on overactive bladder
Updates in the nonpharmacological treatment on overactive bladder Overactive Bladder Also known as urgency-frequency syndrome Symptoms Urgency Daytime frequency Nocturia Urge urinary incontinence Sudden
More informationUrodynamics in women. Aims of Urodynamics in women. Why do Urodynamics?
Urodynamics in women Chendrimada Madhu MD, MA, MRCOG Subspecialty Trainee in Urogynaecology Southmead Hospital 2013 Aims of Urodynamics in women n Confirmation of incontinence and its cause n Definition
More informationRefractory Lower Urinary Tract Symptoms
Sacral Neuromodulation for Treatment of Refractory Lower Urinary Tract Symptoms Alex Kavanagh, PGY3 Mar 30/2011 Goals 1. Define sacral neuromodulation (SNM) and review the clinical implementation 2. Provide
More informationDuloxetine in women awaiting surgery
DOI: 1.1111/j.1471-528.6.879.x www.blackwellpublishing.com/bjog Review article H Drutz Ontario Power Generation Building, Toronto, Ontario, Canada Correspondence: Prof. Dr H Drutz, Mount Sinai Hospital,
More information김준철 가톨릭대학교의과대학비뇨기과학교실
비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related
More informationDiagnosis and Treatment of Urinary Incontinence. Urinary Incontinence
Diagnosis and Treatment of Urinary Incontinence Leslee L. Subak, MD Professor Obstetrics, Gynecology & RS Epidemiology, Urology University of California, San Francisco Urinary Incontinence Common - 25%
More informationPrimary Care management of Overactive Bladder (OAB)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Primary Care management of Overactive Bladder (OAB) Prescribing Tips All medicines for OAB have similar dose-related efficacy. More than one agent (up
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence in women: the management of urinary incontinence in women 1.1 Short title Urinary incontinence in women
More informationOveractive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based
Overactive bladder (OAB) affects approximately 15% of the adult population. Diagnosis is based upon a medical history, and includes a focused physical exam (abdominal, neurological, pelvic in females and
More informationUrogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018
Urogynecology in EDS Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018 One in three like me Voiding Issues Frequency/Urgency Urinary Incontinence neurogenic bladder Neurologic supply
More informationPRE-OPERATIVE URODYNAMIC
PRE-OPERATIVE URODYNAMIC STUDIES: IS THERE VALUE IN PREDICTING POST-OPERATIVE STRESS URINARY INCONTINENCE IN WOMEN UNDERGOING PROLAPSE SURGERY? Dr K Janse van Rensburg Dr JA van Rensburg INTRODUCTION POP
More informationDee E. Fenner, M.D. Chair and Furlong Professor of Women s Health Dept. of Obstetrics and Gynecology University of Michigan.
Management of Overactive Bladder Dee E. Fenner, M.D. Chair and Furlong Professor of Women s Health Dept. of Obstetrics and Gynecology University of Michigan deef@umich.edu Disclosures NONE Objectives Review
More informationEvaluation and Treatment of Incontinence
Evaluation and Treatment of Incontinence Classification of Incontinence Failure to empty: Overflow incontinence Failure to store Stress Incontinence Urge Incontinence Physiology of voiding CNS Brain sends
More informationDiagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center
Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition
More informationUrogynecology Associates of Philadelphia URODYNAMIC TESTING
URODYNAMIC TESTING Urogynecology Associates of Philadelphia Most women with urinary incontinence will need to complete a few simple tests, performed in the office, to help your doctor assess your symptoms
More informationOveractive bladder. Information for patients from Urogynaecology
Overactive bladder Information for patients from Urogynaecology An overactive bladder (OAB) is a very common problem. It can cause distressing symptoms that are difficult to control. These can include
More informationComparison of Symptom Severity and Treatment Response in Patients with Incontinent and Continent Overactive Bladder
European Urology European Urology 48 (2005) 110 115 Female UrologyöIncontinence Comparison of Symptom Severity and Treatment Response in Patients with Incontinent and Continent Overactive Bladder Martin
More informationVarious Types. Ralph Boling, DO, FACOG
Various Types Ralph Boling, DO, FACOG The goal of this lecture is to increase assessment and treatment abilities for physicians managing urinary incontinence (UI) patients. 1. Effectively communicate with
More informationManagement, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence
Management, Evaluation, and Treatment of Overactive Bladder and Urinary Incontinence Arthur Mourtzinos, MD, MBA Co-Vice Chair, Institute of Urology Director, Continence Center Assistant Professor of Urology,
More informationNEUROGENIC BLADDER. Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph
NEUROGENIC BLADDER Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph OUTLINE Definition Anatomy and physiology of bladder function Types of neurogenic bladder Assessment and management Complications
More informationIs There a Best Drug for Overactive Bladder in a Patient with Dementia?
Is There a Best Drug for Overactive Bladder in a Patient with Dementia? Todd Semla, MS, Pharm.D., BCPS, FCCP, AGSF National PBM Clinical Pharmacy Program Manager Mental Health & Geriatrics U.S. Department
More informationCDEC FINAL RECOMMENDATION
CDEC FINAL RECOMMENDATION MIRABEGRON (Myrbetriq Astellas Pharma Canada Inc.) Indication: Overactive Bladder Recommendation: The Canadian Drug Expert Committee (CDEC) recommends that mirabegron be listed
More informationURINARY INCONTINENCE
Center for Continence Care and Pelvic Medicine What is urinary incontinence? URINARY INCONTINENCE Urinary incontinence is the uncontrollable loss of urine. The amount of urine leaked can vary from only
More informationSupplement. Updated Literature Search for Pharmacologic Treatments for Urgency UI
Supplement. Updated Literature Search for Pharmacologic Treatments for Urgency UI Authors: Tatyana A. Shamliyan, MD, MS Senior Director, Evidence-Based Medicine Quality Assurance Elsevier 1600 JFK Blvd,
More informationContent. Terminology Anatomy Aetiology Presentation Classification Management
Prolapse Content Terminology Anatomy Aetiology Presentation Classification Management Terminology Prolapse Descent of pelvic organs into the vagina Cystocele ant. vaginal wall involving bladder Uterine
More informationPaediatric Urotherapy Training
Paediatric Urotherapy Training Frances Shit NS, MSc (Hons), ET, Dept. of Surgery, PWH, CUHK HKSAR Urinary Incontinence in Children Urine leakage in a child from 5 years of age Leakage occurs on a regular
More informationAssociation of BPH with OAB: The Plumbing or the Pump?
Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic
More informationTaking Control of your Bladder, or. Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence
Taking Control of your Bladder, or Don't make me laugh when laughter isn't the best medicine: a discussion on urinary incontinence Brett Vassallo, MD, FACOG, FAC Female Pelvic Medicine and Reconstructive
More informationAccording to the INDICATIONS AND USAGE section of its FDA-approved product labeling (PI):
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Karen L. Walles, M.S. Assistant Director, Regulatory Affairs 3
More informationUrinary incontinence in women
Urinary incontinence in women Lauren N Wood, 1 Jennifer T Anger 2 1 Cedars-Sinai Medical Center, Department of Surgery, Division of Urology, Los Angeles, CA, USA 2 Urologic Reconstruction, Urodynamics,
More informationStress Incontinence. Susannah Elvy Urogynaecology CNS
Stress Incontinence Susannah Elvy Urogynaecology CNS Definitions Prevalence Assessment Investigation Treatment Surgery Men International Continence Society define as the complaint of any involuntary leakage
More informationBJUI. Validity and reliability of the patient s perception of intensity of urgency scale in overactive bladder
; 2010 Lower Urinary Tract PATIENT S PERCEPTION OF INTENSITY OF URGENCY SCALE IN OAB CARTWRIGHT ET AL. BJUI Validity and reliability of the patient s perception of intensity of urgency scale in overactive
More informationPatient Information. Basic Information on Overactive Bladder Symptoms. pubic bone. urethra. scrotum. bladder. vaginal canal
Patient Information English Basic Information on Overactive Bladder Symptoms The underlined terms are listed in the glossary. What is the bladder? pubic bone bladder seminal vesicles prostate rectum The
More informationUP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT
UP DATE MANAGEMENT OF URINARY INCONTINENCE IN ADULT Yunizaf, MD Division of Urogynecology Department of Obstetrics and Gynecology School of Medicine, University of Indonesia/ Dr. Cipto Mangunkusumo Hospital
More informationBladder dysfunction in ALD and AMN
Bladder dysfunction in ALD and AMN Sara Simeoni, MD Department of Uro-Neurology National Hospital for Neurology and Neurosurgery Queen Square, London 10:15 Dr Sara Simeoni- Bladder issues for AMN patients
More informationTreatment of OAB in postmenopause. Držislav Kalafatić Department Obstetrics and Gynecology School of Medicine, University of Zagreb
Treatment of OAB in postmenopause Držislav Kalafatić Department Obstetrics and Gynecology School of Medicine, University of Zagreb Spectrum of overactive bladder Urinary urgency usually accompanied by
More informationWhat is Nocturia? What are the Consequences of Nocturia? 23/10/12. Dr. Tam Cheuk Kwan Consultant, Dept. of M&G Tuen Mun Hospital
Survival 23/10/12 Dr. Tam Cheuk Kwan Consultant, Dept. of M&G Tuen Mun Hospital What is Nocturia? Nocturia is the complaint that the individual has to wake at night one or more times to void. (ICS definition
More informationNeuropathic Bladder. Magda Kujawa Consultant Urologist Stockport NHS Foundation Trust 12/03/2014
Neuropathic Bladder Magda Kujawa Consultant Urologist Stockport NHS Foundation Trust 12/03/2014 Plan Physiology- bladder and sphincter behaviour in neurological disease Clinical consequences of Symptoms
More informationGeriatric Giants Lecture Series: Urinary incontinence
Geriatric Giants Lecture Series: Urinary incontinence Learning objectives To demonstrate an understanding of : definition of urinary incontinence physiological control of the micturition cycle changes
More informationOveractive Bladder: Diagnosis and Approaches to Treatment
Overactive Bladder: Diagnosis and Approaches to Treatment A Hidden Condition* Many Many patients self-manage by voiding frequently, reducing fluid intake, and wearing pads Nearly Nearly two-thirds thirds
More informationDr. Melissa Kagarise, PA C
Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of
More informationVoiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.
Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.
More informationManagement of urinary incontinence in older people Shashi Gadgil BSc, MRCP and Adrian Wagg FRCP
Management of urinary incontinence in older people Shashi Gadgil BSc, MRCP and Adrian Wagg FRCP Prevalence (%) 40 35 30 25 20 15 10 5 Our series Prescribing in older people gives practical advice for successful
More information5 Conservative Treatment for. Pelvic Floor Disorders
5 Conservative Treatment for Pelvic Floor Disorders 23 Pharmacologic Approach to Urinary Incontinence and Voiding Disorders K.-E. Andersson Introduction The main components of the lower urinary tract,
More informationDiagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. TARGET POPULATION Eligibility Decidable (Y or N) Inclusion Criterion non-neurogenic OAB Exclusion Criterion
More informationDr Jonathan Evans Paediatric Nephrologist
How do I manage a patient with intractable daytime wetting: Dr Jonathan Evans Paediatric Nephrologist Of 107 children aged 11-12 with day-wetting 91 (85%) were dry at 15-16 yr Swithinbank et al BJU 1998
More informationOperative Approach to Stress Incontinence. Goals of presentation. Preoperative evaluation: Urodynamic Testing? Michelle Y. Morrill, M.D.
Operative Approach to Stress Incontinence Goals of presentation Michelle Y. Morrill, M.D. Director of Urogynecology The Permanente Medical Group Kaiser, San Francisco Review preoperative care & evaluation
More informationOVERACTIVE BLADDER (OAB)
OVERACTIVE BLADDER (OAB) Ms Taryn Hallam Alana Health Care for Women Women s Health Training Associates OVERACTIVE BLADDER The most misdiagnosed and misunderstood of all the urinary disorders. Problem???
More informationCoping with urges and leaks?
OAB AND YOU Coping with urges and leaks? Let me help you learn more about overactive bladder (OAB) symptoms and ways to help manage them 1 HOW DOES THE BLADDER WORK? Within the urinary tract, the kidneys
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence: the management of urinary incontinence in women 1.1 Short title Urinary incontinence 2 Background a) The National
More informationThe Management of Female Urinary Incontinence. Part 1: Aetiology and Investigations
The Management of Female Urinary Incontinence Part 1: Aetiology and Investigations Dr Oseka Onuma Gynaecologist and Pelvic Reconstructive Surgeon 4 Robe Terrace Medindie SA 5081 Urinary incontinence has
More information25-Feb-16 MANAGEMENT OF URINARY INCONTINENCE IN WOMEN.
Female Urinary Incontinence: GP resources MANAGEMENT OF URINARY INCONTINENCE IN WOMEN Dr Marcus Carey 20 February 2016 www.thewomens.org.au Clinical Practice Guidelines GP management of female urinary
More informationOveractive Bladder. When to see a doctor. Normal bladder function
Overactive Bladder Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary
More informationUrinary incontinence is a common symptom that
Urinary incontinence Urinary incontinence, as defined by The International Continence Society, is the complaint of any involuntary leakage of urine. 1 Urinary incontinence is a common problem throughout
More informationMr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.
Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations
More informationThe Management of Overactive Bladder Syndrome with Antimuscarinic Drugs
The Management of Overactive Bladder Syndrome with Antimuscarinic Drugs Author Version Date Consultation Date of Ratification By JPG Shaista Hussain Joint Formulary Pharmacist V2 16.09.2014 Homerton University
More informationCENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July-August
BRAND NAME Noctiva GENERIC NAME Desmopressin acetate nasal spray MANUFACTURER Serenity Pharmaceuticals DATE OF APPROVAL March 3, 2017 PRODUCT LAUNCH DATE TBD REVIEW TYPE Review type 1 (RT1): New Drug Review
More informationPresentation Goals 4/14/2015. Pharmacology for Urinary Incontinence in Women. Medications Review anti muscarinic medications Focus on newer meds
Presentation Goals Pharmacology for Urinary Incontinence in Women Medications Review anti muscarinic medications Focus on newer meds Introduce beta adrenergic medications Current Concepts in Drug Therapy
More informationTable 1. International Consultation on Incontinence recommendations for frail older adults
Table 1. International Consultation on Incontinence recommendations for frail older adults Clinicians need to assess and manage co-existing co morbid conditions which are known to have an impact on continence
More informationPelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS
Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS OhioHealth, Columbus Ohio Disclosures I have nothing to disclose Objectives Describe the role of a pelvic floor therapist in
More informationReport on New Patented Drugs Enablex
Report on New Patented Drugs Enablex Under its transparency initiative, the PMPRB publishes the results of the reviews of new patented drugs by Board Staff, for purposes of applying the PMPRB s Excessive
More information